Efficacy and safety of asenapine in Asian patients with an acute exacerbation of schizophrenia: a multicentre, randomized, double-blind, 6-week, placebo-controlled study

Toshihiko Kinoshita,Ya-Mei Bai,Jong-Hoon Kim,Mutsuo Miyake,Nobuyuki Oshima

Efficacy and safety of asenapine in Asian patients with an acute exacerbation of schizophrenia: a multicentre, randomized, double-blind, 6-week, placebo-controlled study

2016

Toshihiko Kinoshita
Ya-Mei Bai
Jong-Hoon Kim
Mutsuo Miyake
Nobuyuki Oshima

Rationale Asenapine is a second generation anti-psychotic approved in the USA in 2009 for the treatment of schizophrenia, but its efficacy has not been proven in Asian patients.

Keywords:

Anesthesia
Prospective cohort study
Psychiatric status rating scales
Psychology
Schizophrenia
Asenapine
Exacerbation
Psychiatry
Placebo-controlled study
Internal medicine
Body weight
Tolerability
double blind
pharmacology toxicology

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations